No Increase in MS Disease Activity Due to COVID-19

COVID-19 has no impact on disease activity, progression, or cognitive performance in patients with multiple sclerosis.

Related Keywords

Italy ,Milan ,Lombardia ,Fondazione Italiana Sclerosi Multipla ,Federico Montini ,Medscape Coronavirus Resource Center ,Coronavirus Resource ,Expanded Disability Status Scale ,Modified Fatigue Impact Scale ,Hospital Anxiety ,Depression Scale ,Pittsburgh Sleep Quality Index ,Event Scale Revised ,San Raffaele Hospital ,Fondazione Italiana Sclerosi ,Multiple Sclerosis Ms ,Multiple Sclerosis ,Us ,Multiple Sclerosis Progression ,Als Progression ,Multiple Sclerosis Treatment ,Als Treatment ,Reatment Of Multiple Sclerosis ,Reatment Of Ms ,Multiple Sclerosis Relapse ,S Relapse ,Elapse Of Multiple Sclerosis ,Elapse Of Ms ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 , ,